91 related articles for article (PubMed ID: 10704292)
1. The human CYP2C locus: a prototype for intergenic and exon repetition splicing events.
Finta C; Zaphiropoulos PG
Genomics; 2000 Feb; 63(3):433-8. PubMed ID: 10704292
[TBL] [Abstract][Full Text] [Related]
2. RNA molecules containing exons originating from different members of the cytochrome P450 2C gene subfamily (CYP2C) in human epidermis and liver.
Zaphiropoulos PG
Nucleic Acids Res; 1999 Jul; 27(13):2585-90. PubMed ID: 10373573
[TBL] [Abstract][Full Text] [Related]
3. Gene structure of CYP2C8 and extrahepatic distribution of the human CYP2Cs.
Klose TS; Blaisdell JA; Goldstein JA
J Biochem Mol Toxicol; 1999; 13(6):289-95. PubMed ID: 10487415
[TBL] [Abstract][Full Text] [Related]
4. A 2.4-megabase physical map spanning the CYP2C gene cluster on chromosome 10q24.
Gray IC; Nobile C; Muresu R; Ford S; Spurr NK
Genomics; 1995 Jul; 28(2):328-32. PubMed ID: 8530044
[TBL] [Abstract][Full Text] [Related]
5. Intergenic transcripts containing a novel human cytochrome P450 2C exon 1 spliced to sequences from the CYP2C9 gene.
Warner SC; Finta C; Zaphiropoulos PG
Mol Biol Evol; 2001 Oct; 18(10):1841-8. PubMed ID: 11557791
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the substrate specificities of human liver cytochrome P450s 2C9 and 2C18: application to the design of a specific substrate of CYP 2C18.
Minoletti C; Dijols S; Dansette PM; Mansuy D
Biochemistry; 1999 Jun; 38(24):7828-36. PubMed ID: 10387023
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional activation of CYP2C, MxA and Fas in sudden infant death syndrome.
Beurton F; Gueret G; Horisberger M; Cheron G; Cresteil T
Int J Mol Med; 1999 Jan; 3(1):33-9. PubMed ID: 9864383
[TBL] [Abstract][Full Text] [Related]
8. Exon skipping and circular RNA formation in transcripts of the human cytochrome P-450 2C18 gene in epidermis and of the rat androgen binding protein gene in testis.
Zaphiropoulos PG
Mol Cell Biol; 1997 Jun; 17(6):2985-93. PubMed ID: 9154796
[TBL] [Abstract][Full Text] [Related]
9. Fluorescence in situ hybridization analysis of chromosomal localization of three human cytochrome P450 2C genes (CYP2C8, 2C9, and 2C10) at 10q24.1.
Inoue K; Inazawa J; Suzuki Y; Shimada T; Yamazaki H; Guengerich FP; Abe T
Jpn J Hum Genet; 1994 Sep; 39(3):337-43. PubMed ID: 7841444
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of sulfaphenazole derivatives and their use as inhibitors and tools for comparing the active sites of human liver cytochromes P450 of the 2C subfamily.
Ha-Duong NT; Dijols S; Marques-Soares C; Minoletti C; Dansette PM; Mansuy D
J Med Chem; 2001 Oct; 44(22):3622-31. PubMed ID: 11606127
[TBL] [Abstract][Full Text] [Related]
11. Analysis of selective regions in the active sites of human cytochromes P450, 2C8, 2C9, 2C18, and 2C19 homology models using GRID/CPCA.
Ridderström M; Zamora I; Fjellström O; Andersson TB
J Med Chem; 2001 Nov; 44(24):4072-81. PubMed ID: 11708911
[TBL] [Abstract][Full Text] [Related]
12. Gene structure and upstream regulatory regions of human CYP2C9 and CYP2C18.
de Morais SM; Schweikl H; Blaisdell J; Goldstein JA
Biochem Biophys Res Commun; 1993 Jul; 194(1):194-201. PubMed ID: 8333835
[TBL] [Abstract][Full Text] [Related]
13. Pharmacogenetics of CYP2C subfamily in a Japanese population.
Ieiri I; Higuchi S
J Toxicol Sci; 1998 Jul; 23 Suppl 2():129-31. PubMed ID: 9760448
[No Abstract] [Full Text] [Related]
14. Characterization of CYP2C19 and CYP2C9 from human liver: respective roles in microsomal tolbutamide, S-mephenytoin, and omeprazole hydroxylations.
Lasker JM; Wester MR; Aramsombatdee E; Raucy JL
Arch Biochem Biophys; 1998 May; 353(1):16-28. PubMed ID: 9578596
[TBL] [Abstract][Full Text] [Related]
15. Intergenic mRNA molecules resulting from trans-splicing.
Finta C; Zaphiropoulos PG
J Biol Chem; 2002 Feb; 277(8):5882-90. PubMed ID: 11726664
[TBL] [Abstract][Full Text] [Related]
16. Novel Cytochrome P450 2C119 Enzymes in Cynomolgus and Rhesus Macaques Metabolize Progesterone, Diclofenac, and Omeprazole.
Uno Y; Murayama N; Yamazaki H
Drug Metab Dispos; 2024 Feb; 52(3):266-273. PubMed ID: 38123944
[TBL] [Abstract][Full Text] [Related]
17. Molecular modelling of human CYP2C subfamily enzymes CYP2C9 and CYP2C19: rationalization of substrate specificity and site-directed mutagenesis experiments in the CYP2C subfamily.
Lewis DF; Dickins M; Weaver RJ; Eddershaw PJ; Goldfarb PS; Tarbit MH
Xenobiotica; 1998 Mar; 28(3):235-68. PubMed ID: 9574814
[TBL] [Abstract][Full Text] [Related]
18. Linkage between the distribution of mutations in the CYP2C18 and CYP2C19 genes in the Japanese and Caucasian.
Inoue K; Yamazaki H; Shimada T
Xenobiotica; 1998 Apr; 28(4):403-11. PubMed ID: 9604303
[TBL] [Abstract][Full Text] [Related]
19. Partial sequence and polymerase chain reaction-mediated analysis of expression of the human CYP2C18 gene.
Ged C; Beaune P
Pharmacogenetics; 1992 Jun; 2(3):109-15. PubMed ID: 1306110
[TBL] [Abstract][Full Text] [Related]
20. Identification of major CYP2C9 and CYP2C19 polymorphisms by fluorescence resonance energy transfer analysis.
Borlak J; Thum T
Clin Chem; 2002 Sep; 48(9):1592-4. PubMed ID: 12194942
[No Abstract] [Full Text] [Related]
[Next] [New Search]
